Precision medicine in Asia enhanced by next‐generation sequencing: Implications for Thailand through a scoping review and interview study

Author:

Phanthunane Chumut1ORCID,Pongcharoen Sutatip2ORCID,Pannarunothai Supasit3ORCID,Roboon Jureepon45ORCID,Phanthunane Pudtan6ORCID,Nontarak Jiraluck7ORCID

Affiliation:

1. Division of Medical Oncology Chulabhorn Hospital, Chulabhorn Royal Academy Bangkok Thailand

2. Department of Medicine, Faculty of Medicine Naresuan University Phitsanulok Thailand

3. Research Unit Centre for Health Equity Monitoring Foundation Phitsanulok Thailand

4. Department of Anatomy, Faculty of Medical Science Naresuan University Phitsanulok Thailand

5. Centre of Excellence in Medical Biotechnology Naresuan University Phitsanulok Thailand

6. Department of Economics, Faculty of Business, Economics and Communications Naresuan University Phitsanulok Thailand

7. Department of Epidemiology, Faculty of Public Health Mahidol University Bangkok Thailand

Abstract

AbstractNext‐generation sequencing (NGS) significantly enhances precision medicine (PM) by offering personalized approaches to diagnosis, treatment, and prevention of unmet medical needs. Little is known about the current situation of PM in Asia. Thus, we aimed to conduct an overview of the progress and gaps in PM in Asia and enrich it with in‐depth insight into the possibilities of future PM in Thailand. This scoping review focused on Asian countries starting with non‐cancer studies, including rare and undiagnosed diseases (RUDs), non‐communicable diseases (NCDs), infectious diseases (IDs), and pharmacogenomics, with a focus on NGS. Subsequent in‐depth interviews with experts in Thailand were performed, and a thematic analysis served as the main qualitative methodology. Out of 2898 searched articles, 387 studies were included after the review. Although most of the studies focused on cancer, 89 (23.0%) studies were related to RUDs (17.1%), NCDs (2.8%), IDs (1.8%), and pharmacogenomics (1.3%). Apart from medicine and related sciences, the studies were mostly composed of PM (61.8%), followed by genetics medicine and bioinformatics. Interestingly, 28% of articles were conducted exclusively within the fields of medicine and related sciences, emphasizing interdisciplinary integration. The experts emphasized the need for sustainability‐driven political will, nurturing collaboration, reinforcing computational infrastructure, and expanding the bioinformatic workforce. In Asia, developments of NGS have made remarkable progress in PM. Thailand has extended PM beyond cancer and focused on clinical implementation. We summarized the PM challenges, including equity and efficiency targeting, guided research funding, sufficient sample size, integrated collaboration, computational infrastructure, and sufficient trained human resources.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3